Artificial Light at Night and Type 2 Diabetes Mellitus
Diabetes & Metabolism Journal · 30.09.2024 · 48 (5) · 847-863
DOI: 10.4093/dmj.2024.0237 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Diabetes & Metabolism Journal, erschienen am 30.09.2024. Verfasst von Jong-Ha Baek und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Internal Medicine, Gyeongsang National University Changwon Hospital, Gyeongsang National University College of Medicine, Changwon, Kore…. Hauptthemen laut MEDLINE: Diabetes Mellitus, Type 2, Circadian Rhythm. Die Arbeit wurde bisher 27-mal zitiert (Crossref) und nennt 129 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: NCATS NIH HHS, NIH HHS, NIEHS NIH HHS.
Themen: Diabetes mellitus
Abstract (Originalsprache)
The widespread and pervasive use of artificial light at night (ALAN) in our modern 24-hour society has emerged as a substantial disruptor of natural circadian rhythms, potentially leading to a rise in unhealthy lifestyle-related behaviors (e.g., poor sleep; shift work). This phenomenon has been associated with an increased risk of type 2 diabetes mellitus (T2DM), which is a pressing global public health concern. However, to date, reviews summarizing associations between ALAN and T2DM have primarily focused on the limited characteristics of exposure (e.g., intensity) to ALAN. This literature review extends beyond prior reviews by consolidating recent studies from 2000 to 2024 regarding associations between both indoor and outdoor ALAN exposure and the incidence or prevalence of T2DM. We also described potential biological mechanisms through which ALAN modulates glucose metabolism. Furthermore, we outlined knowledge gaps and investigated how various ALAN characteristics beyond only light intensity (including light type, timing, duration, wavelength, and individual sensitivity) influence T2DM risk. Recognizing the detrimental impact of ALAN on sleep health and the behavioral correlates of physical activity and dietary patterns, we additionally summarized studies investigating the potential mediating role of each component in the relationship between ALAN and glucose metabolism. Lastly, we proposed implications of chronotherapies and chrononutrition for diabetes management in the context of ALAN exposure.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Internal Medicine, Gyeongsang National University Changwon Hospital, Gyeongsang National University College of Medicine, Changwon, Korea.
- Department of Epidemiology, Fay W. Boozman College of Public Health, University of Arkansas for Medical Sciences, Little Rock, AR, USA.
- Winthrop P. Rockefeller Cancer Institute, University of Arkansas for Medical Sciences, Little Rock, AR, USA.
- Epidemiology Branch, National Institute of Environmental Health Sciences, Research Triangle Park, NC, USA.
- Division of Intramural Research, National Institute on Minority Health and Health Disparities, National Institutes of Health, Bethesda, MD, USA.
Förderung
- NCATS NIH HHS
- NIH HHS
- NIEHS NIH HHS
- Gyeongsang National University
- National Institute of Environmental Health Sciences
- National Center for Advancing Translational Sciences
- National Institutes of Health
Zitieren
APA
Baek, J. H., Zhu, Y., Jackson, C. L., & Park, Y. M. (2024). Artificial Light at Night and Type 2 Diabetes Mellitus. Diabetes & Metabolism Journal, 48(5), 847-863. https://doi.org/10.4093/dmj.2024.0237
Vancouver
Baek JH, Zhu Y, Jackson CL, Park YM. Artificial Light at Night and Type 2 Diabetes Mellitus. Diabetes & Metabolism Journal. 2024;48(5):847-863. doi:10.4093/dmj.2024.0237
BibTeX
@article{Baek2024,
author = {Baek, Jong-Ha and Zhu, Yong and Jackson, Chandra L and Park, Yong-Moon Mark},
title = {Artificial Light at Night and Type 2 Diabetes Mellitus},
journal = {Diabetes & Metabolism Journal},
year = {2024},
volume = {48},
number = {5},
pages = {847--863},
doi = {10.4093/dmj.2024.0237}
}
EUVIMED